Global mRNA COVID-19 Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Page: 99
Published Date: 29 Jul 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global mRNA COVID-19 Vaccine market size was valued at USD 4352.5 million in 2022 and is forecast to a readjusted size of USD 4745.9 million by 2029 with a CAGR of 1.2% during review period.
Messenger ribonucleic acid (mRNA) is a molecule that provides cells with instructions for making proteins. mRNA vaccines contain the instructions for making the SARS-CoV-2 spike protein. This protein is found on the surface of the virus that causes COVID-19. The mRNA molecule is essentially a recipe, telling the cells of the body how to make the spike protein. mRNA COVID-19 Vaccines are given by injection, usually into the muscle of the upper arm.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the mRNA COVID-19 Vaccine industry chain, the market status of Children (Non-replicating mRNA Vaccine, Self-amplifying mRNA Vaccine), Adults (Non-replicating mRNA Vaccine, Self-amplifying mRNA Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of mRNA COVID-19 Vaccine.
Regionally, the report analyzes the mRNA COVID-19 Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global mRNA COVID-19 Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the mRNA COVID-19 Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the mRNA COVID-19 Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Non-replicating mRNA Vaccine, Self-amplifying mRNA Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the mRNA COVID-19 Vaccine market.
Regional Analysis: The report involves examining the mRNA COVID-19 Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the mRNA COVID-19 Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to mRNA COVID-19 Vaccine:
Company Analysis: Report covers individual mRNA COVID-19 Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards mRNA COVID-19 Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Children, Adults).
Technology Analysis: Report covers specific technologies relevant to mRNA COVID-19 Vaccine. It assesses the current state, advancements, and potential future developments in mRNA COVID-19 Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the mRNA COVID-19 Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
mRNA COVID-19 Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Non-replicating mRNA Vaccine
Self-amplifying mRNA Vaccine
Market segment by Application
Children
Adults
Major players covered
Moderna
CanSino Biologicals
Pfizer
Fosun-Pharmaceutical
CSPC Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe mRNA COVID-19 Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of mRNA COVID-19 Vaccine, with price, sales, revenue and global market share of mRNA COVID-19 Vaccine from 2018 to 2023.
Chapter 3, the mRNA COVID-19 Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the mRNA COVID-19 Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and mRNA COVID-19 Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of mRNA COVID-19 Vaccine.
Chapter 14 and 15, to describe mRNA COVID-19 Vaccine sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of mRNA COVID-19 Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global mRNA COVID-19 Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Non-replicating mRNA Vaccine
1.3.3 Self-amplifying mRNA Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global mRNA COVID-19 Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Children
1.4.3 Adults
1.5 Global mRNA COVID-19 Vaccine Market Size & Forecast
1.5.1 Global mRNA COVID-19 Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global mRNA COVID-19 Vaccine Sales Quantity (2018-2029)
1.5.3 Global mRNA COVID-19 Vaccine Average Price (2018-2029)
2.1 Moderna
2.1.1 Moderna Details
2.1.2 Moderna Major Business
2.1.3 Moderna mRNA COVID-19 Vaccine Product and Services
2.1.4 Moderna mRNA COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Moderna Recent Developments/Updates
2.2 CanSino Biologicals
2.2.1 CanSino Biologicals Details
2.2.2 CanSino Biologicals Major Business
2.2.3 CanSino Biologicals mRNA COVID-19 Vaccine Product and Services
2.2.4 CanSino Biologicals mRNA COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CanSino Biologicals Recent Developments/Updates
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer mRNA COVID-19 Vaccine Product and Services
2.3.4 Pfizer mRNA COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Pfizer Recent Developments/Updates
2.4 Fosun-Pharmaceutical
2.4.1 Fosun-Pharmaceutical Details
2.4.2 Fosun-Pharmaceutical Major Business
2.4.3 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Product and Services
2.4.4 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Fosun-Pharmaceutical Recent Developments/Updates
2.5 CSPC Pharmaceutical
2.5.1 CSPC Pharmaceutical Details
2.5.2 CSPC Pharmaceutical Major Business
2.5.3 CSPC Pharmaceutical mRNA COVID-19 Vaccine Product and Services
2.5.4 CSPC Pharmaceutical mRNA COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 CSPC Pharmaceutical Recent Developments/Updates
3.1 Global mRNA COVID-19 Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global mRNA COVID-19 Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global mRNA COVID-19 Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of mRNA COVID-19 Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 mRNA COVID-19 Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 mRNA COVID-19 Vaccine Manufacturer Market Share in 2022
3.5 mRNA COVID-19 Vaccine Market: Overall Company Footprint Analysis
3.5.1 mRNA COVID-19 Vaccine Market: Region Footprint
3.5.2 mRNA COVID-19 Vaccine Market: Company Product Type Footprint
3.5.3 mRNA COVID-19 Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global mRNA COVID-19 Vaccine Market Size by Region
4.1.1 Global mRNA COVID-19 Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global mRNA COVID-19 Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global mRNA COVID-19 Vaccine Average Price by Region (2018-2029)
4.2 North America mRNA COVID-19 Vaccine Consumption Value (2018-2029)
4.3 Europe mRNA COVID-19 Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific mRNA COVID-19 Vaccine Consumption Value (2018-2029)
4.5 South America mRNA COVID-19 Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa mRNA COVID-19 Vaccine Consumption Value (2018-2029)
5.1 Global mRNA COVID-19 Vaccine Sales Quantity by Type (2018-2029)
5.2 Global mRNA COVID-19 Vaccine Consumption Value by Type (2018-2029)
5.3 Global mRNA COVID-19 Vaccine Average Price by Type (2018-2029)
6.1 Global mRNA COVID-19 Vaccine Sales Quantity by Application (2018-2029)
6.2 Global mRNA COVID-19 Vaccine Consumption Value by Application (2018-2029)
6.3 Global mRNA COVID-19 Vaccine Average Price by Application (2018-2029)
7.1 North America mRNA COVID-19 Vaccine Sales Quantity by Type (2018-2029)
7.2 North America mRNA COVID-19 Vaccine Sales Quantity by Application (2018-2029)
7.3 North America mRNA COVID-19 Vaccine Market Size by Country
7.3.1 North America mRNA COVID-19 Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America mRNA COVID-19 Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8.1 Europe mRNA COVID-19 Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe mRNA COVID-19 Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe mRNA COVID-19 Vaccine Market Size by Country
8.3.1 Europe mRNA COVID-19 Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe mRNA COVID-19 Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9.1 Asia-Pacific mRNA COVID-19 Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific mRNA COVID-19 Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific mRNA COVID-19 Vaccine Market Size by Region
9.3.1 Asia-Pacific mRNA COVID-19 Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific mRNA COVID-19 Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10.1 South America mRNA COVID-19 Vaccine Sales Quantity by Type (2018-2029)
10.2 South America mRNA COVID-19 Vaccine Sales Quantity by Application (2018-2029)
10.3 South America mRNA COVID-19 Vaccine Market Size by Country
10.3.1 South America mRNA COVID-19 Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America mRNA COVID-19 Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11.1 Middle East & Africa mRNA COVID-19 Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa mRNA COVID-19 Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa mRNA COVID-19 Vaccine Market Size by Country
11.3.1 Middle East & Africa mRNA COVID-19 Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa mRNA COVID-19 Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12.1 mRNA COVID-19 Vaccine Market Drivers
12.2 mRNA COVID-19 Vaccine Market Restraints
12.3 mRNA COVID-19 Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13.1 Raw Material of mRNA COVID-19 Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of mRNA COVID-19 Vaccine
13.3 mRNA COVID-19 Vaccine Production Process
13.4 mRNA COVID-19 Vaccine Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 mRNA COVID-19 Vaccine Typical Distributors
14.3 mRNA COVID-19 Vaccine Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global mRNA COVID-19 Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global mRNA COVID-19 Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Moderna Basic Information, Manufacturing Base and Competitors
Table 4. Moderna Major Business
Table 5. Moderna mRNA COVID-19 Vaccine Product and Services
Table 6. Moderna mRNA COVID-19 Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Moderna Recent Developments/Updates
Table 8. CanSino Biologicals Basic Information, Manufacturing Base and Competitors
Table 9. CanSino Biologicals Major Business
Table 10. CanSino Biologicals mRNA COVID-19 Vaccine Product and Services
Table 11. CanSino Biologicals mRNA COVID-19 Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. CanSino Biologicals Recent Developments/Updates
Table 13. Pfizer Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Major Business
Table 15. Pfizer mRNA COVID-19 Vaccine Product and Services
Table 16. Pfizer mRNA COVID-19 Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Pfizer Recent Developments/Updates
Table 18. Fosun-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Fosun-Pharmaceutical Major Business
Table 20. Fosun-Pharmaceutical mRNA COVID-19 Vaccine Product and Services
Table 21. Fosun-Pharmaceutical mRNA COVID-19 Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Fosun-Pharmaceutical Recent Developments/Updates
Table 23. CSPC Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. CSPC Pharmaceutical Major Business
Table 25. CSPC Pharmaceutical mRNA COVID-19 Vaccine Product and Services
Table 26. CSPC Pharmaceutical mRNA COVID-19 Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. CSPC Pharmaceutical Recent Developments/Updates
Table 28. Global mRNA COVID-19 Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 29. Global mRNA COVID-19 Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 30. Global mRNA COVID-19 Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 31. Market Position of Manufacturers in mRNA COVID-19 Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 32. Head Office and mRNA COVID-19 Vaccine Production Site of Key Manufacturer
Table 33. mRNA COVID-19 Vaccine Market: Company Product Type Footprint
Table 34. mRNA COVID-19 Vaccine Market: Company Product Application Footprint
Table 35. mRNA COVID-19 Vaccine New Market Entrants and Barriers to Market Entry
Table 36. mRNA COVID-19 Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global mRNA COVID-19 Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 38. Global mRNA COVID-19 Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 39. Global mRNA COVID-19 Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 40. Global mRNA COVID-19 Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 41. Global mRNA COVID-19 Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 42. Global mRNA COVID-19 Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 43. Global mRNA COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 44. Global mRNA COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 45. Global mRNA COVID-19 Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 46. Global mRNA COVID-19 Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 47. Global mRNA COVID-19 Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 48. Global mRNA COVID-19 Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 49. Global mRNA COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 50. Global mRNA COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 51. Global mRNA COVID-19 Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 52. Global mRNA COVID-19 Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 53. Global mRNA COVID-19 Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 54. Global mRNA COVID-19 Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 55. North America mRNA COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 56. North America mRNA COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 57. North America mRNA COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 58. North America mRNA COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 59. North America mRNA COVID-19 Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 60. North America mRNA COVID-19 Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 61. North America mRNA COVID-19 Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 62. North America mRNA COVID-19 Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 63. Europe mRNA COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Europe mRNA COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Europe mRNA COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 66. Europe mRNA COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 67. Europe mRNA COVID-19 Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 68. Europe mRNA COVID-19 Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 69. Europe mRNA COVID-19 Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 70. Europe mRNA COVID-19 Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 71. Asia-Pacific mRNA COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 72. Asia-Pacific mRNA COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 73. Asia-Pacific mRNA COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 74. Asia-Pacific mRNA COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 75. Asia-Pacific mRNA COVID-19 Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 76. Asia-Pacific mRNA COVID-19 Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 77. Asia-Pacific mRNA COVID-19 Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 78. Asia-Pacific mRNA COVID-19 Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 79. South America mRNA COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 80. South America mRNA COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 81. South America mRNA COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 82. South America mRNA COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 83. South America mRNA COVID-19 Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 84. South America mRNA COVID-19 Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 85. South America mRNA COVID-19 Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 86. South America mRNA COVID-19 Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 87. Middle East & Africa mRNA COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 88. Middle East & Africa mRNA COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 89. Middle East & Africa mRNA COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 90. Middle East & Africa mRNA COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 91. Middle East & Africa mRNA COVID-19 Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 92. Middle East & Africa mRNA COVID-19 Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 93. Middle East & Africa mRNA COVID-19 Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 94. Middle East & Africa mRNA COVID-19 Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 95. mRNA COVID-19 Vaccine Raw Material
Table 96. Key Manufacturers of mRNA COVID-19 Vaccine Raw Materials
Table 97. mRNA COVID-19 Vaccine Typical Distributors
Table 98. mRNA COVID-19 Vaccine Typical Customers
List of Figures
Figure 1. mRNA COVID-19 Vaccine Picture
Figure 2. Global mRNA COVID-19 Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global mRNA COVID-19 Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Non-replicating mRNA Vaccine Examples
Figure 5. Self-amplifying mRNA Vaccine Examples
Figure 6. Global mRNA COVID-19 Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global mRNA COVID-19 Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Children Examples
Figure 9. Adults Examples
Figure 10. Global mRNA COVID-19 Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global mRNA COVID-19 Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global mRNA COVID-19 Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 13. Global mRNA COVID-19 Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 14. Global mRNA COVID-19 Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global mRNA COVID-19 Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of mRNA COVID-19 Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 mRNA COVID-19 Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 mRNA COVID-19 Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global mRNA COVID-19 Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global mRNA COVID-19 Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America mRNA COVID-19 Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe mRNA COVID-19 Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific mRNA COVID-19 Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America mRNA COVID-19 Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa mRNA COVID-19 Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global mRNA COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global mRNA COVID-19 Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global mRNA COVID-19 Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global mRNA COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global mRNA COVID-19 Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global mRNA COVID-19 Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America mRNA COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America mRNA COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America mRNA COVID-19 Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America mRNA COVID-19 Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States mRNA COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada mRNA COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico mRNA COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe mRNA COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe mRNA COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe mRNA COVID-19 Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe mRNA COVID-19 Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany mRNA COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France mRNA COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom mRNA COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia mRNA COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy mRNA COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific mRNA COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific mRNA COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific mRNA COVID-19 Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific mRNA COVID-19 Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China mRNA COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan mRNA COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea mRNA COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India mRNA COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia mRNA COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia mRNA COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America mRNA COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America mRNA COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America mRNA COVID-19 Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America mRNA COVID-19 Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil mRNA COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina mRNA COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa mRNA COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa mRNA COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa mRNA COVID-19 Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa mRNA COVID-19 Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey mRNA COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt mRNA COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia mRNA COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa mRNA COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. mRNA COVID-19 Vaccine Market Drivers
Figure 73. mRNA COVID-19 Vaccine Market Restraints
Figure 74. mRNA COVID-19 Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of mRNA COVID-19 Vaccine in 2022
Figure 77. Manufacturing Process Analysis of mRNA COVID-19 Vaccine
Figure 78. mRNA COVID-19 Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Moderna CanSino Biologicals Pfizer Fosun-Pharmaceutical CSPC Pharmaceutical
Related Reports
29 Jul 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
